322 related articles for article (PubMed ID: 25214840)
1. Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.
Ragazzi M; Ciarrocchi A; Sancisi V; Gandolfi G; Bisagni A; Piana S
Int J Endocrinol; 2014; 2014():790834. PubMed ID: 25214840
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
Pan Z; Lu X; Xu T; Chen J; Bao L; Li Y; Gong Y; Che Y; Zou X; Tan Z; Huang P; Ge M
Cancer Lett; 2024 Jan; 580():216496. PubMed ID: 37993084
[TBL] [Abstract][Full Text] [Related]
3. PAX8 expression in anaplastic thyroid carcinoma is less than those reported in early studies: a multi-institutional study of 182 cases using the monoclonal antibody MRQ-50.
Lai WA; Hang JF; Liu CY; Bai Y; Liu Z; Gu H; Hong S; Pyo JY; Jung CK; Kakudo K; Bychkov A
Virchows Arch; 2020 Mar; 476(3):431-437. PubMed ID: 31732814
[TBL] [Abstract][Full Text] [Related]
4. Clear Cell Variant of Papillary Thyroid Carcinoma With Associated Anaplastic Thyroid Carcinoma: Description of an Extraordinary Case.
Juhlin CC; Höög A
Int J Surg Pathol; 2019 Sep; 27(6):658-663. PubMed ID: 30931661
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
[TBL] [Abstract][Full Text] [Related]
6. REGγ ablation impedes dedifferentiation of anaplastic thyroid carcinoma and accentuates radio-therapeutic response by regulating the Smad7-TGF-β pathway.
Jiao C; Li L; Zhang P; Zhang L; Li K; Fang R; Yuan L; Shi K; Pan L; Guo Q; Gao X; Chen G; Xu S; Wang Q; Zuo D; Wu W; Qiao S; Wang X; Moses R; Xiao J; Li L; Dang Y; Li X
Cell Death Differ; 2020 Feb; 27(2):497-508. PubMed ID: 31243343
[TBL] [Abstract][Full Text] [Related]
7. MMP1 acts as a potential regulator of tumor progression and dedifferentiation in papillary thyroid cancer.
Zhou J; Xu M; Tan J; Zhou L; Dong F; Huang T
Front Oncol; 2022; 12():1030590. PubMed ID: 36479070
[TBL] [Abstract][Full Text] [Related]
8. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
Gómez Sáez JM; Jiménez-Fonseca P; Santamaría Sandi J; Capdevila Castillón J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Riesco Eizaguirre G; Grande Pulido E; Galofré Ferrater JC
Endocrinol Nutr; 2015 Mar; 62(3):e15-22. PubMed ID: 25583658
[TBL] [Abstract][Full Text] [Related]
9. Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer.
Saini S; Maker AV; Burman KD; Prabhakar BS
Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188262. PubMed ID: 30605717
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.
Deeken-Draisey A; Yang GY; Gao J; Alexiev BA
Hum Pathol; 2018 Dec; 82():140-148. PubMed ID: 30075157
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic Carcinoma Thyroid in a Young Child - an Extremely Rare Occurrence.
Sharma SC; Sakthivel P; Raveendran S; Singh CA; Nakra T; Agarwal S
Acta Medica (Hradec Kralove); 2018; 61(4):150-152. PubMed ID: 30664448
[TBL] [Abstract][Full Text] [Related]
12. Coexisting Papillary and Anaplastic Thyroid Cancer: Elucidating the Spectrum of Aggressive Behavior.
Greenberg JA; Moore MD; Thiesmeyer JW; Egan CE; Lee YJ; Christos P; Zarnegar R; Beninato T; Fahey Iii TJ; Finnerty BM
Ann Surg Oncol; 2023 Jan; 30(1):137-145. PubMed ID: 36224511
[TBL] [Abstract][Full Text] [Related]
13. Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.
Teng L; Deng W; Lu J; Zhang J; Ren X; Duan H; Chuai S; Duan F; Gao W; Lu T; Wu H; Liang Z
Oncotarget; 2017 Mar; 8(13):22023-22033. PubMed ID: 28423545
[TBL] [Abstract][Full Text] [Related]
14. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
[TBL] [Abstract][Full Text] [Related]
15. mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch.
Hébrant A; Dom G; Dewaele M; Andry G; Trésallet C; Leteurtre E; Dumont JE; Maenhaut C
PLoS One; 2012; 7(10):e37807. PubMed ID: 23115614
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Anaplastic and Papillary Thyroid Carcinoma Manifesting as a Thyrocutaneous Fistula.
Razzak Kamel S; Shu Jiun K; Arasu K; Muhammad Zuhaidi K; Mohan Singh AS
Cureus; 2023 Dec; 15(12):e49990. PubMed ID: 38179358
[TBL] [Abstract][Full Text] [Related]
18. LINC00886 Negatively Regulates Malignancy in Anaplastic Thyroid Cancer.
Ma B; Luo Y; Xu W; Han L; Liu W; Liao T; Yang Y; Wang Y
Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36726346
[TBL] [Abstract][Full Text] [Related]
19. Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature.
Ragazzi M; Torricelli F; Donati B; Ciarrocchi A; de Biase D; Tallini G; Zanetti E; Bisagni A; Kuhn E; Giordano D; Frasoldati A; Piana S
Virchows Arch; 2021 Feb; 478(2):265-281. PubMed ID: 32683537
[TBL] [Abstract][Full Text] [Related]
20. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer.
Tesselaar MH; Crezee T; Schuurmans I; Gerrits D; Nagarajah J; Boerman OC; van Engen-van Grunsven I; Smit JWA; Netea-Maier RT; Plantinga TS
J Nucl Med; 2018 May; 59(5):780-786. PubMed ID: 29242405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
